1. Home
  2. LCID vs KLRA Comparison

LCID vs KLRA Comparison

Compare LCID & KLRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lucid Group Inc.

LCID

Lucid Group Inc.

HOLD

Current Price

$3.57

Market Cap

1.5B

ML Signal

HOLD

Logo Kailera Therapeutics Inc. Common Stock

KLRA

Kailera Therapeutics Inc. Common Stock

HOLD

Current Price

$12.75

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LCID
KLRA
Founded
2007
2024
Country
United States
United States
Employees
N/A
N/A
Industry
Auto Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.4B
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
LCID
KLRA
Price
$3.57
$12.75
Analyst Decision
Hold
Strong Buy
Analyst Count
11
6
Target Price
$7.39
★ $42.40
AVG Volume (30 Days)
★ 9.4M
1.3M
Earning Date
11-09-2026
11-23-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $595,271,000.00
N/A
Revenue This Year
$14.22
N/A
Revenue Next Year
$125.39
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.37
$9.76
52 Week High
$19.47
$23.82

Technical Indicators

Market Signals
Indicator
LCID
KLRA
Relative Strength Index (RSI) 41.12 52.61
Support Level $2.37 $9.76
Resistance Level $4.44 $19.15
Average True Range (ATR) 0.26 0.86
MACD 0.03 0.44
Stochastic Oscillator 43.24 82.09

Price Performance

Historical Comparison
LCID
KLRA

About LCID Lucid Group Inc.

Lucid Group Inc is a technology and automotive company. It develops the next generation of electric vehicle (EV) technologies. It offers its own geographically distributed retail and service locations through direct-to-consumer online and retail sales. It also boasts a product roadmap of future vehicle programs and technologies. It focuses on in-house hardware and software innovation, vertical integration, and a clean-sheet approach to engineering and design, which led to the development of the Lucid Air. The Lucid Air is a luxury sedan that redefines both the luxury car segment and the EV space. Its geographic segments include North America, the Middle East, and Other International.

About KLRA Kailera Therapeutics Inc. Common Stock

Kailera Therapeutics Inc is a clinical-stage biotechnology company. The company focuses on developing a diversified pipeline to provide options for people living with obesity. The company is progressing four clinical-stage product candidates, leveraging multiple GLP-1 based mechanisms of action and routes of administration. The company's obesity-first approach seeks to advance product candidates with the potential to maximize weight loss and address critical needs in the current therapeutic landscape.

Share on Social Networks: